About Zoliget Tablet 30 mg / 4 mg
Zoliget 30 mg/4 mg is a higher strength pioglitazone and glimepiride combination for type 2 diabetes management.
Zoliget Tablet 30 mg / 4 mg Uses
- Type 2 diabetes mellitus in patients not adequately controlled on lower strength combinations
- Step up therapy after titration from Zoliget 15 mg/2 mg or equivalent separate doses
- Long term blood sugar management in patients requiring a stronger combined dose
Zoliget Tablet 30 mg / 4 mg Benefits
- A stronger combined dose for patients who plateau on lower strength therapy
- The same two mechanism approach carried forward at an intensified level
- Single tablet convenience even at the higher dose range
- Sustained glycemic support for long standing type 2 diabetes
What Experts Say
Zoliget combines pioglitazone, a thiazolidinedione, with glimepiride, a sulfonylurea, in a higher combined strength. Pioglitazone activates PPAR gamma receptors in fat and muscle tissue to improve insulin sensitivity, while glimepiride prompts the pancreas to secrete more insulin. Both mechanisms work at an intensified level in this strength.
The 30 mg/4 mg strength is generally reserved for patients whose blood sugar remains above target on lower strength combinations or on the individual drugs separately. It represents a step up in therapy rather than a first choice, chosen once initial doses have been tolerated well.
Because glimepiride content is higher, hypoglycemia awareness becomes more important, particularly around meal timing and exercise. Clinicians typically monitor HbA1c, liver enzymes and signs of fluid retention more closely at this dose, adjusting further therapy only after reviewing these results.
Drug Class
- Thiazolidinedione (Pioglitazone)
- Sulfonylurea (Glimepiride)
- Oral antidiabetic combination
Zoliget Tablet 30 mg / 4 mg Uses in Urdu
زولی گیٹ ٹیبلٹ ٹائپ ٹو ذیابیطس میں خون کی شوگر کو قابو میں رکھنے کے لیے استعمال ہوتی ہے۔ اس میں دو دوائیں شامل ہیں جو مل کر بہتر نتائج دیتی ہیں۔
- جب کم طاقت کی خوراک سے شوگر مکمل طور پر قابو میں نہ آئے
- ٹائپ 2 ذیابیطس کے طویل المدتی علاج کے لیے
- زیادہ خوراک درکار مریضوں میں بلڈ شوگر کو مستحکم رکھنے کے لیے
Zoliget Tablet 30 mg / 4 mg formula
- Pioglitazone + Glimepiride
How to use Zoliget Tablet 30 mg / 4 mg?
- One tablet taken once daily with the first main meal of the day
- The tablet should be swallowed whole and not crushed or chewed
- Consistent daily timing supports stable blood sugar levels at this higher strength
- Meals should not be skipped or delayed after taking this medicine
- Any further dose change should only follow a doctor's review of blood sugar readings
Drug Interactions
Zoliget Tablet 30 mg / 4 mg can interact with several other medicines, so tell your doctor about everything you are taking.
- Alcohol: Higher risk of hypoglycemia at this stronger glimepiride dose, along with possible lactic acid disturbances
- Beta blockers: Warning signs of low blood sugar, such as a fast heartbeat, may be masked
- Other antidiabetic drugs including insulin: Combined use raises hypoglycemia risk and needs careful dose adjustment
- Gemfibrozil: Pioglitazone levels may rise, increasing side effect risk
- Rifampicin: Pioglitazone levels may fall, reducing its effect
- NSAIDs and salicylates: Blood sugar lowering effect of glimepiride may be enhanced, raising hypoglycemia risk further at this dose
Risks and warnings
- Hypoglycemia risk: Higher glimepiride content raises the chance of low blood sugar compared with lower strength tablets
- Fluid retention: Swelling, sudden weight gain or breathlessness may signal worsening heart failure
- Maximum dose: This strength approaches the upper glimepiride dose range, so further increases need careful medical review
- Bladder cancer: Cumulative pioglitazone exposure at higher doses carries a small increased bladder cancer risk
- Liver function: Regular liver enzyme checks are recommended, particularly at this stronger dose
Zoliget Tablet 30 mg / 4 mg Side Effects
Zoliget Tablet 30 mg / 4 mg is generally well tolerated when used as directed, though some effects can still appear.
- Hypoglycemia (low blood sugar)
- Weight gain
- Swelling in the legs or ankles
- Headache
- Upper respiratory tract infection
- Muscle or joint pain
- Dizziness
- Nausea
- Mild anemia
Contact your doctor immediately if any of these serious reactions occur.
- Signs of heart failure such as sudden weight gain, shortness of breath, or leg swelling (rare with pioglitazone)
- Severe hypoglycemia with confusion or loss of consciousness, needing urgent treatment
Storage Conditions
- Store below 30°C in a dry place away from direct sunlight
- Keep the tablets in their original blister pack until ready to use
- Keep out of reach of children
- Do not use after the expiry date printed on the pack
